Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes

American Journal of Pathology

Volumn 168, Issue 5, 2006, Pages 1631-1641

  Kasprzycka, Monika ^a,b   Majewski, Miroslaw ^a,c   Wang, Zhi Jong ^a   Ptasznik, Andrzej ^a   Wysocka, Maria ^a   Zhang, Qian ^a   Marzec, Michal ^a   Gimotty, Phyllis ^a   Crompton, Mark R ^d   Wasik, Mariusz A ^a,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA; MOUSE; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 33646506878     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050521     Document Type: Article

References (29)

1. Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ, Gusterson BA, Crompton MR: Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene 1994, 9:2383-2390
2. Vasioukhin V, Serfas MS, Siyanova EY, Polonskaia M, Costigan VJ, Liu B, Thomason A, Tyner AL: A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract. Oncogene 1995, 10:349-357
3. Serfas MS, Tyner AL: Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol Res 2003, 13:409-419
4. Barker KT, Jackson LE, Crompton MR: BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 1997, 15:799-805
5. Zhao C, Yasui K, Lee CJ, Kurioka H, Hosokawa Y, Oka T, Inazawa J: Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. Cancer 2003, 98:18-23
6. Born M, Quintanilia-Fend L, Braselmann H, Reich U, Richter M, Hutzler P, Aubele M: Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J Pathol 2005, 205:592-596
7. Easty DJ, Mitchell PJ, Patel K, Florenes VA, Spritz RA, Bennett DC: Loss of expression of receptor tyrosine kinase famiiy genes PTK7 and SEK in metastatic meianoma. Int J Cancer 1997, 71:1061-1065
8. Lior X, Serfas MS, Bie W, Vasioukhin V, Polonskaia M, Derry J, Abbott CM, Tyner AL: BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin Cancer Res 1999, 5:1767-1777
9. Lin HS, Berry GJ, Fee Jr WE, Terris DJ, Sun Z: Identification of tyrosine kinases overexpressed in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004, 130:311-316
10. Petro BJ, Tan RC, Tyner AL, Lingen MW, Watanabe K: Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium. Oral Oncol 2004, 40:1040-1047
11. Wang TC, Jee SH, Tsai TF, Huang YL, Tsai WL, Chen RH: Role of breast tumour kinase in the in vitro differentiation of HaCaT cells. Br J Dermatol 2005, 153:282-289
12. Vasioukhin V, Tyner AL: A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation. Proc Natl Acad Sci USA 1997, 94:14477-14482
13. Derry JJ, Prins GS, Ray V, Tyner AL: Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 2003, 22:4212-4220
14. Kamalati T, Jolin HE, Mitcheil PJ, Barker KT, Jackson LE, Dean CJ, Page MJ, Gusterson BA, Crompton MR: Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J Biol Chem 1996, 271:30956-30963
15. Kim HI, Lee ST: An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6. J Biol Chem 2005, 280:28973-28980
16. Harvey AJ, Crompton MR: Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 2003, 22:5006-5010
17. Lukong KE, Larocque D, Tyner AL, Richard S: Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem 2005, 280:38639-38647
18. Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH: Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol 2004, 24:10558-10572
19. Haegebarth A, Nunez R, Tyner AL: The intracellular tyrosine kinase Brk sensitizes non-transformed cells to inducers of apoptosis. Cell Cycle 2005, 4:1239-1246
20. Wang ZY, Zhang Q, Wilson J, Ratajczak MZ, Wasik MA: Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific PCR and parallel denaturing gradient gel electrophoresis (DGGE). J Mol Diagn 2003, 5:113-120
21. Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA: Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J Immunol 2002, 168:466-474
22. Wlodarski P, Kasprzycka M, Liu X, Marzec M, Slupianek A, Wasik MA: Activation of mTOR in transformed B lymphocytes is nutrient-dependent but independent of Akt MEK, IGF-I, and serum. Cancer Res 2005, 65:7800-7808
23. Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM: Short interfering RNA (SiRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR- ABL1(+) leukemia cells. Nat Med 2004, 10:1187-1189
24. Qiu H, Miller WT: Regulation of the nonreceptortyrosine kinase Brk by autophosphorylation and by autoinhibition. J Biol Chem 2002, 277:34634-34641
25. Majewski M, Korecka M, Kossev P, Li S, Goldman J, Moore J, Silberstein L, Nowell PC, Schuler W, Shaw LM, Wasik MA: The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc Natl Acad Sci USA 2000, 97:4285-4290
26. Derry JJ, Richard S, Valderrama Carvajal H, Ye X, Vasioukhin V, Cochrane AW, Chen T, Tyner AL: Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol Cell Biol 2000, 20:6114-6126
27. Kamalati T, Jolin HE, Fry MJ, Crompton MR: Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to Pl 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 2000, 19:5471-5476
28. Zhang P, Ostrander JH, Faivre EJ, Olsen A, Fitzsimmons D, Lange CA: Regulated association of protein kinase b/akt with breast tumor kinase. J Biol Chem 2005, 280:1982-1991
29. Haegebarth A, Heap D, Bie W, Derry JJ, Richard S, Tyner AL: The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. J Biol Chem 2004, 279:54398-54404